Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balapiravir + Pegasys + Copegus in Treatment-naïve Chronic Hepatitis C
NCT00517439Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2007
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 9
01
Overview
A Phase 2 trial of balapiravir in hepatitis C (HCV), sponsored by Roche. Started Dec 2007; status: completed.
02
Drugs
balapiravir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00517439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517439.